NORTH CHICAGO, Ill.,
March 1, 2022 /PRNewswire/
-- AbbVie (NYSE: ABBV) will participate in the Cowen
42nd Annual Health Care Conference on Tuesday, March 8, 2021. Robert A. Michael, vice chairman, finance and
commercial operations and chief financial officer, Michael E. Severino, M.D., vice chairman and
president, and Jeffrey R. Stewart,
executive vice president, chief commercial officer, will present
virtually at 11:50 a.m. Central
Time.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
About AbbVie
AbbVie's mission is to discover and
deliver innovative medicines that solve serious health issues today
and address the medical challenges of tomorrow. We strive to have a
remarkable impact on people's lives across several key therapeutic
areas: immunology, oncology, neuroscience, eye care, virology,
women's health and gastroenterology, in addition to products and
services across its Allergan Aesthetics portfolio. For more
information about AbbVie, please visit us at www.abbvie.com.
Follow @abbvie on Twitter, Facebook, Instagram, YouTube and
LinkedIn.
View original
content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-cowen-42nd-annual-health-care-conference-301492085.html
SOURCE AbbVie